{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:43:48Z","timestamp":1768635828148,"version":"3.49.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This article highlights the most recent advances in a review of the current literature in the field of pediatric heart failure and transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Diagnostically, the identification of new genetic factors has contributed to a deeper understanding of cardiomyopathy in children. Novel medications like sacubitril\/valsartan and Sodium-Glucose cotransporter-2 (SGLT2) inhibitors, which are now standard in the adult population are being studied in pediatric population and offer new promise of pediatric heart failure treatment. Ventricular assist devices are more commonly used in cardiomyopathy patients and single ventricle patients as a bridge to transplant. Recent pediatric heart transplant society (PHTS) data demonstrated that waitlist survival improved significantly over the past decades (i) and new treatments such as daratumumab and eculizumab have been used in high-risk populations and demonstrate promising results. TEAMMATE trial is the first multicenter randomized clinical trial (RCT) in pediatric heart transplant (HT) to evaluate the safety and efficacy of everolimus (EVL) and low-dose tacrolimus (TAC) compared to standard-dose TAC and mycophenolate mofetil (MMF). It will provide valuable information about the safety and efficacy of EVL, TAC, and MMF (ii).<\/jats:p>\n            <jats:p>Donor cell-free DNA has been used more in pediatric transplant recipients and has significantly decreased invasive EMB (iii).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>This past 5 years have witness dramatic progress in the field of pediatric heart failure and transplantation including more use of mechanical support in heart failure patients with various underlying etiology, especially use of mechanical support in single ventricle patients and the use of sacubitril\/valsartan and SGLT2 inhibitors in the pediatric population. The problem of the highly sensitized transplant recipient remains, although novel therapeutics have been added to our toolbox of options to maintain healthy allograft function. Ongoing research aims to further enhance our understanding and management of pediatric heart failure, emphasizing the need for continued innovation in this complex field.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001393","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:41:59Z","timestamp":1725968519000},"page":"489-495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Advances in understanding and managing pediatric heart failure and transplant"],"prefix":"10.1097","volume":"36","author":[{"given":"Wenyuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"e14615","DOI":"10.1111\/petr.14615","article-title":"Three decades of collaboration through the Pediatric Heart Transplant Society Registry: a journey through registry data with a highlight on children with single ventricle anatomy","volume":"28","author":"Richmond","year":"2024","journal-title":"Pediatr Transplant"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","article-title":"Heart failure in pediatric patients with congenital heart disease","volume":"120","author":"Hinton","year":"2017","journal-title":"Circ Res"},{"issue":"(Suppl 2)","key":"R4-20250730","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1017\/S1047951115000852","article-title":"Clinical management of patients with acute heart failure","volume":"25","author":"Rossano","year":"2015","journal-title":"Cardiol Young"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00246-017-1787-2","article-title":"Systematic literature review on the incidence and prevalence of heart failure in children and adolescents","volume":"39","author":"Shaddy","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpeds.2014.04.055","article-title":"Heart failure in children: etiology and treatment","volume":"165","author":"Rossano","year":"2014","journal-title":"J Pediatr"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"e006101","DOI":"10.1161\/CIRCHEARTFAILURE.119.006101","article-title":"Epidemiology and outcomes of acute decompensated heart failure in children","volume":"13","author":"Lasa","year":"2020","journal-title":"Circ Heart Fail"},{"key":"R8-20250730","first-page":"e240","article-title":"2013\u200aACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Writing Committee","year":"2013","journal-title":"Circulation"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00246-012-0306-8","article-title":"The Ross classification for heart failure in children after 25\u200ayears: a review and an age-stratified revision","volume":"33","author":"Ross","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved? On using chemical energy to support cardiac function","volume":"95","author":"Ingwall","year":"2004","journal-title":"Circ Res"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart - -an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.RES.0000060027.40275.A6","article-title":"Is depressed myocyte contractility centrally involved in heart failure?","volume":"92","author":"Houser","year":"2003","journal-title":"Circ Res"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41390-021-01548-w","article-title":"Integrated analysis of miRNA-mRNA interaction in pediatric dilated cardiomyopathy","volume":"92","author":"Hailu","year":"2022","journal-title":"Pediatr Res"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","article-title":"Noncoding RNAs in cardiac remodeling and heart failure","volume":"113","author":"Kumarswamy","year":"2013","journal-title":"Circ Res"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"H1308","DOI":"10.1152\/ajpheart.00511.2019","article-title":"Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failure","volume":"318","author":"Toni","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ehf2.13182","article-title":"Combination of ivabradine and sacubitril\/valsartan in patients with heart failure and reduced ejection fraction","volume":"8","author":"Lee","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"R22-20250730","first-page":"e895","article-title":"2022\u200aAHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"e009816","DOI":"10.1161\/CIRCHEARTFAILURE.122.009816","article-title":"Baseline characteristics of pediatric patients with heart failure due to systemic left ventricular systolic dysfunction in the PANORAMA-HF trial","volume":"16","author":"Shaddy","year":"2023","journal-title":"Circ Heart Fail"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.healun.2024.01.012","article-title":"Sacubitril-valsartan vs ACE\/ARB in pediatric heart failure: a retrospective cohort study","volume":"43","author":"Hale","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.037778","article-title":"Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial","volume":"139","author":"Fitchett","year":"2019","journal-title":"Circulation"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","article-title":"Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jchf.2022.10.005","article-title":"How to initiate and uptitrate GDMT in heart failure: practical stepwise approach to optimization of GDMT","volume":"10","author":"Bozkurt","year":"2022","journal-title":"JACC Heart Fail"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00246-022-02983-0","article-title":"Early clinical experience with dapagliflozin in children with heart failure","volume":"44","author":"Newland","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"R31-20250730","article-title":"Experience with SGLT2 inhibitors in patients with single ventricle congenital heart disease and fontan circulatory failure","author":"Konduri","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"R32-20250730","first-page":"5243594","article-title":"Feasibility and safety of sodium glucose cotransporter-2 inhibitors in adults with heart failure after the fontan procedure","volume":"2022","author":"Muneuchi","year":"2022","journal-title":"Case Rep Cardiol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjcard.2007.11.023","article-title":"Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers","volume":"101","author":"Flannery","year":"2008","journal-title":"Am J Cardiol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-012-0467-8","article-title":"Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study","volume":"102","author":"B\u00f6hm","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2012.01.020","article-title":"Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Findings from the SHIFT (Systolic Heart failure treatment with the I f inhibitor ivabradine Trial) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.semtcvs.2018.03.003","article-title":"Worldwide experience of a durable centrifugal flow pump in pediatric patients","volume":"30","author":"Conway","year":"2018","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"e13031","DOI":"10.1111\/petr.13031","article-title":"Ventricular assist device use in single ventricle congenital heart disease","volume":"21","author":"Carlo","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MAT.0000000000000983","article-title":"Bridge to transplant with ventricular assist device support in pediatric patients with single ventricle heart disease","volume":"66","author":"Chen","year":"2020","journal-title":"ASAIO J"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.healun.2018.10.008","article-title":"Outcomes of children with congenital heart disease implanted with ventricular assist devices: An analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs)","volume":"38","author":"Peng","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.pcsu.2016.09.010","article-title":"Current status of pediatric ventricular assist device support","volume":"20","author":"Adachi","year":"2017","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.healun.2020.02.007","article-title":"Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: a multicenter registry analysis","volume":"39","author":"O\u2019Connor","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report-2019; focus theme: Donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.healun.2017.10.021","article-title":"Outcome after heart transplantation from donation after circulatory-determined death donors","volume":"36","author":"Messer","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"e13244","DOI":"10.1111\/petr.13244","article-title":"Waste not, want not: maximizing use of pediatric marginal donor hearts","volume":"22","author":"Kirk","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1097\/TP.0000000000004719","article-title":"New desensitization strategy: daratumumab for highly sensitized pediatric heart transplant candidate","volume":"107","author":"Baez Hernandez","year":"2023","journal-title":"Transplantation"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003505","article-title":"Daratumumab for antibody-mediated rejection in heart transplant-a novel therapy: successful treatment of antibody-mediated rejection","volume":"105","author":"Aguilera Agudo","year":"2021","journal-title":"Transplantation"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOT.0000000000000411","article-title":"Current concepts for sensitized patients before transplantation","volume":"22","author":"Geft","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"e14214","DOI":"10.1111\/petr.14214","article-title":"Rejection surveillance in pediatric heart transplant recipients: critical reflection on the role of frequent and long-term routine surveillance endomyocardial biopsies and comprehensive review of noninvasive rejection screening tools","volume":"26","author":"Power","year":"2022","journal-title":"Pediatr Transplant"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"e13622","DOI":"10.1111\/petr.13622","article-title":"Early changes in cell-free DNA levels in newly transplanted heart transplant patients","volume":"24","author":"Zangwill","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jtcvs.2022.04.027","article-title":"Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults","volume":"165","author":"Richmond","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"e14264","DOI":"10.1111\/petr.14264","article-title":"Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation","volume":"26","author":"Deshpande","year":"2022","journal-title":"Pediatr Transplant"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:01:20Z","timestamp":1753898480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001393","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]}}}